Auflistung: nach Autor Vogt, U.
1 bis 6 von 6 Treffer
| Erscheinungsdatum | Titel | Autor(en) |
|---|---|---|
| 2003 | A case of blastic natural killer cell lymphoma with rapidly progressive multi-organ involvement | Trapp, M.; Innig, G.; Bosse, U.; Vogt, U.; Koch, O.M. |
| 2003 | A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer | Granetzny, Andreas; E, Striehn; Bosse, U.; Wagner, Wolfgang; Koch, Olaf M.; Vogt, U.; Froeschle, Peter; Klinke, Folker |
| 2003 | C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer | Schlotter, C. M.; Vogt, U.; Bosse, U.; Mersch, Berthold; Waβmann, Katja |
| 2012 | Correlation between in vitro chemotherapy sensitivity and PARP-1 expression in patients with breast cancer. | Liedtke, Cornelia; Packeisen, J; Denkert, Carsten; Kiesel, Ludwig; Vogt, U.; Mueller, Berit; Hess, Kenneth R.; Buerger, Horst |
| 2013 | ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer. | Marra, Alessandro; Kemming, Dirk; Krueer, Thomas; Bosse, U.; Netchaeva, Maria; Wagner, Wolfgang; Koch, Olaf M.; Vogt, U.; Hillejan, Ludger |
| 2012 | Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes | Liedtke, Cornelia; Packeisen, J; Hess, Kenneth R.; Vogt, U.; Kiesel, Ludwig; Kersting, Christian; Korsching, Eberhardt; Brandt, Burkhard; Buerger, Horst |